2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ranirestat: new trials by email Literature Review of ranirestat trials Research Report on ranirestat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy Ranirestat, Placebo - Mild to Moderate Diabetic Sensorimotor Polyneuropathy | Phase 2 / Phase 3 | Completed | Eisai Inc. | 800 | 2009-07-01 | 2019-02-21 |
| Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy ranirestat, (AS-3201) - Diabetic Neuropathy | Phase 3 | Completed | Sumitomo Pharma Co., Ltd. | 500 | 2004-10-01 | 2008-01-14 |
Eisai Inc. (1) · Sumitomo Pharma Co., Ltd. (1)
Canada (1) · United States (1)
Roderick Junor (1)
2008 (1)